Skip to main content

Osteoporosis

  • Chapter
  • First Online:
Practical Clinical Endocrinology
  • 978 Accesses

Abstract

Osteoporosis is a metabolic bone disease characterized by progressive loss of bone mass and qualitative changes in microarchitecture, resulting in high prevalence of fragility fractures. The disease is most common in older ladies, but older men and younger people with some chronic diseases or medications are also involved. Osteoporosis yearly causes more than nine million fractures in the world, followed by enormous medical and social costs, higher mortality, and decreased quality of life. However, established methods for diagnosis and treatment have been developed in the last decades, ensuring good chance for fracture prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  1. Blake G, Adams JE, Bishop N. Chapter 30: DXA in adults and children. In: Rosen CJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 8th ed. Somerset: Wiley; 2013. p. 249–63.

    Chapter  Google Scholar 

  2. Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N, Hope S, Kanis JA, McCloskey EV, Poole KES, Reid DM, Selby P, Thompson F, Thurston A, Vine N. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2017;12:43. https://doi.org/10.1007/s11657-017-0324-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361:756–65. https://doi.org/10.1056/NEJMoa0809493.

    Article  CAS  PubMed  Google Scholar 

  4. Eekman DA, van Helden SH, Huisman AM, Verhaar HJ, Bultink IE, Geusens PP, Lips P, Lems WF. Optimizing fracture prevention: the fracture liaison service, an observational study. Osteoporos Int. 2014;25:701–9. https://doi.org/10.1007/s00198-013-2481-8.

    Article  CAS  PubMed  Google Scholar 

  5. Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV. A systematic review of intervention thresholds based on FRAX: a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos. 2016;11:25. https://doi.org/10.1007/s11657-016-0278-z.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kanis JA, Harvey NC, McCloskey E, Bruyère O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N, Campusano C, Chandran M, Dawson-Hughes B, Javaid K, Jiwa F, Johansson H, Lee JK, Liu E, Messina D, Mkinsi O, Pinto D, Prieto-Alhambra D, Saag K, Xia W, Zakraoui L, Reginster J-Y. Algorithm for the management of patients at low/middle/high risk of osteoporotic fracture: a global perspective. Osteoporos Int. 2019;31:1–12. https://doi.org/10.1007/s00198-019-05176-3.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kanis JA, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30:3–44. https://doi.org/10.1007/s00198-018-4704-5.

    Article  CAS  PubMed  Google Scholar 

  8. Kraenzlin ME, Meier C. Parathyroid hormone analogues in the treatment of osteoporosis. Nat Rev Endocrinol. 2011;7:647–56. https://doi.org/10.1038/nrendo.2011.108.

    Article  CAS  PubMed  Google Scholar 

  9. Rizzoli R, Burlet N, Cahall D, Delmas PD, Eriksen EF, Felsenberg D, Grbic J, Jontell M, Landesberg R, Laslop A, Wollenhaupt M, Papapoulos S, Sezer O, Sprafka M, Reginster JY. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone. 2008;42:841–7. https://doi.org/10.1016/j.bone.2008.01.003.

    Article  CAS  PubMed  Google Scholar 

  10. University of Sheffield. FRAX fracture risk assessment tool. 2008. https://www.sheffield.ac.uk/FRAX/.

  11. Watts NB. Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA). Osteoporos Int. 2004;15:847–54. https://doi.org/10.1007/s00198-004-1681-7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Csaba Horvath .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Horvath, C. (2021). Osteoporosis. In: Igaz, P. (eds) Practical Clinical Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-030-62011-0_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-62011-0_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-62010-3

  • Online ISBN: 978-3-030-62011-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics